4.7 Article

A Multicenter Randomized Clinical Trial of Primary Anastomosis or Hartmann's Procedure for Perforated Left Colonic Diverticulitis With Purulent or Fecal Peritonitis

Journal

ANNALS OF SURGERY
Volume 256, Issue 5, Pages 819-827

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0b013e31827324ba

Keywords

colonic perforation; diverticulitis; Hartmann's procedure; protective ileostomy; rectosigmoid resection

Categories

Ask authors/readers for more resources

Objectives: To evaluate the outcome after Hartmann's procedure (HP) versus primary anastomosis (PA) with diverting ileostomy for perforated left-sided diverticulitis. Background: The surgical management of left-sided colonic perforation with purulent or fecal peritonitis remains controversial. PA with ileostomy seems to be superior to HP; however, results in the literature are affected by a significant selection bias. No randomized clinical trial has yet compared the 2 procedures. Methods: Sixty-two patients with acute left-sided colonic perforation (Hinchey III and IV) from 4 centers were randomized to HP (n = 30) and to PA (with diverting ileostomy, n = 32), with a planned stoma reversal operation after 3 months in both groups. Data were analyzed on an intention-to-treat basis. The primary end point was the overall complication rate. The study was discontinued following an interim analysis that found significant differences of relevant secondary end points as well as a decreasing accrual rate (NCT01233713). Results: Patient demographics were equally distributed in both groups (Hinchey III: 76% vs 75% and Hinchey IV: 24% vs 25%, for HP vs PA, respectively). The overall complication rate for both resection and stoma reversal operations was comparable (80% vs 84%, P = 0.813). Although the outcome after the initial colon resection did not show any significant differences (mortality 13% vs 9% and morbidity 67% vs 75% in HP vs PA), the stoma reversal rate after PA with diverting ileostomy was higher (90% vs 57%, P = 0.005) and serious complications (Grades IIIb-IV: 0% vs 20%, P = 0.046), operating time (73 minutes vs 183 minutes, P < 0.001), hospital stay (6 days vs 9 days, P = 0.016), and lower in-hospital costs (US $ 16,717 vs US $ 24,014) were significantly reduced in the PA group. Conclusions: This is the first randomized clinical trial favoring PA with diverting ileostomy over HP in patients with perforated diverticulitis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis Tumor Biology Cuts the Deal

Dilmurodjon Eshmuminov, Debora J. Studer, Victor Lopez Lopez, Marcel A. Schneider, Jan Lerut, Mary Lo, Linda Sher, Thomas J. Musholt, Oana Lozan, Nabila Bouzakri, Carlo Sposito, Rosalba Miceli, Shoma Barat, David Morris, Helga Oehler, Teresa Schreckenbach, Peri Husen, Charles B. Rosen, Gregory J. Gores, Toshihiko Masui, Tan-To Cheung, Corina Kim-Fuchs, Aurel Perren, Philipp Dutkowski, Henrik Petrowsky, Espen Thiis-Evensen, Pal-Dag Line, Michal Grat, Stefano Partelli, Massimo Falconi, Lulu Tanno, Ricardo Robles-Campos, Vincenzo Mazzaferro, Pierre-Alain Clavien, Kuno Lehmann

Summary: This multicenter study compares the outcomes of liver resection (LR) and liver transplantation (LT) in patients with neuroendocrine liver metastasis (NELM). The results suggest that LT provides a survival benefit over LR, but adherence to selection criteria is important.

ANNALS OF SURGERY (2023)

Article Gastroenterology & Hepatology

Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?

Andrea Balla, Federica Saraceno, Marika Rullo, Salvador Morales-Conde, Eduardo M. Targarona Soler, Salomone Di Saverio, Mario Guerrieri, Pasquale Lepiane, Nicola Di Lorenzo, Michel Adamina, Isaias Alarcon, Alberto Arezzo, Jesus Bollo Rodriguez, Luigi Boni, Sebastiano Biondo, Francesco Maria Carrano, Manish Chand, John T. Jenkins, Justin Davies, Salvadora Delgado Rivilla, Paolo Delrio, Ugo Elmore, Eloy Espin-Basany, Alessandro Fichera, Blas Flor Lorente, Nader Francis, Marcos Gomez Ruiz, Dieter Hahnloser, Eugenio Licardie, Carmen Martinez, Monica Ortenzi, Yves Panis, Carlos Pastor Idoate, Alessandro M. Paganini, Miguel Pera, Roberto Perinotti, Daniel A. Popowich, Timothy Rockall, Riccardo Rosati, Alberto Sartori, Daniele Scoglio, Mostafa Shalaby, Vicente Simo Fernandez, Neil J. Smart, Antonino Spinelli, Patricia Sylla, Pieter J. Tanis, Javier Valdes-Hernandez, Steven D. Wexner, Pierpaolo Sileri

Summary: This qualitative study investigated the decision-making process of surgeons regarding protective ileostomy creation after rectal cancer surgery. The results showed that 76% of surgeons supported the creation of ileostomy. When making the decision, 88% of surgeons considered risk factors. Emotions influenced the decision-making process in 22% of cases, and personal experiences influenced it in 49% of cases. The most frequently considered risk factors were the distance between the anus and the tumor (96%), neoadjuvant chemoradiotherapy (88%), positive intraoperative leak test (65%), blood loss (37%), and immunosuppression therapy (35%).

COLORECTAL DISEASE (2023)

Letter Gastroenterology & Hepatology

Posterior perineal hernia repair with perineal approach: a video vignette

Philip Deslarzes, Serena Faes, Michael Winiker, Nicolas Demartines, Dieter Hahnloser

COLORECTAL DISEASE (2023)

Article Oncology

Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC

Lilian Roth, Dilmurodjon Eshmuminov, Linda Russo, Felix Laminger, Friedrich Kober, Sebastian Roka, Kuno Lehmann

Summary: This study aimed to assess the sensitivity and specificity of blood and serum markers after CRS/HIPEC. It found that HIPEC alters the diagnostic sensitivity and specificity of these markers, with PCT identified as a highly specific marker for diagnosing infectious complications after CRS/HIPEC.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review

Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raef Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel Andre Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Roessler, Victor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal

Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Kuno Lehmann

ANNALS OF SURGICAL ONCOLOGY (2023)

Review Oncology

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review

Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raef Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel Andre Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rossler, Victor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann

Summary: Pancreatic cancer often presents as locally advanced or borderline resectable. It is currently unclear which chemotherapy is preferred for patients in these categories. This study found that initial treatment with FOLFIRINOX appears to provide a survival benefit for patients that are ultimately unresectable, compared to gemcitabine-based chemotherapy.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?

Rahel Stiefel, Kuno Lehmann, Thomas Winder, Alexander R. Siebenhuener

Summary: This study aimed to analyze the outcomes of GEP-NETs treatment and compare them with the latest treatment recommendations. The results showed that treatment steps and stages of GEP-NETs were related to survival rates. Surgery was commonly used in both early and advanced stages, while the use of Somatostatine-Agonist as a drug treatment was also common.

BMC CANCER (2023)

Review Oncology

A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma

Styliani Mantziari, Penelope St Amour, Francesco Abboretti, Hugo Teixeira-Farinha, Sergio Gaspar Figueiredo, Caroline Gronnier, Dimitrios Schizas, Nicolas Demartines, Markus Schafer

Summary: Despite recent therapeutical advances, gastric adenocarcinoma remains associated with a poor long-term survival. Diagnosis is often made at advanced stages, affecting prognosis. Factors such as tumor microenvironment, patient ethnicity, and therapeutic strategy play a role in patient outcome. This study aims to review existing knowledge on prognostic factors in gastric adenocarcinoma.

CANCERS (2023)

Review Oncology

Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov

Kristjan Ukegjini, Marisa Guidi, Kuno Lehmann, Krisztian Sueveg, Paul Martin Putora, Nikola Cihoric, Thomas Steffen

Summary: This study analyzed HIPEC trials registered on ClinicalTrials.gov to identify their focus and assess publication of trial results. Among 234 identified trials, 11% were published and 6% reported results but not as full papers. Most trials were recruiting patients (36%) or completed but unpublished (20%). The majority of trials focused on treatment strategies (68%) and oncological outcomes (53%). The most studied neoplasms were peritoneally metastasized colorectal cancer, gastric cancer, and ovarian cancer.

CANCERS (2023)

Article Surgery

Prospective compliance assessment of surgical site infection prevention measures in colorectal surgery

Philip Deslarzes, Jonas Jurt, Martin Hubner, Dieter Hahnloser, Daniel Clerc, Laurence Senn, Nicolas Demartines, Fabian Grass

BJS OPEN (2023)

Review Medicine, General & Internal

Pancreatic Cancer Surgery: What Matters to Patients?

David Martin, Piero Alberti, Stephen J. Wigmore, Nicolas Demartines, Gaetan-Romain Joliat

Summary: Pancreatic cancer is a deadly disease with unknown origins and limited treatment options. Surgical resection, the primary curative treatment, is associated with high morbidity and mortality rates and frequent recurrence. Patient-centered care and understanding patient perspectives are crucial for improving outcomes in pancreatic cancer surgery. Standardized patient-reported outcome and experience measures are needed to assess patient perspectives accurately.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization

Alessa Fischer, Umberto Maccio, Katharina Wang, Juliane Friemel, Martina A. Broglie Daeppen, Diana Vetter, Kuno Lehmann, Astrid Reul, Mercedes Robledo, Constanze Hantel, Nicole Bechmann, Karel Pacak, Kathrin Zitzmann, Christoph J. Auernhammer, Ashley B. Grossman, Felix Beuschlein, Svenja Noelting

Summary: In pheochromocytomas and paragangliomas, hypoxia upregulates the expression of PD-L1 and HIF-2 alpha, promoting tumor progression and immune microenvironment alterations. Head and neck paragangliomas undergoing embolization show significantly higher expression levels of PD-L1 and HIF-2 alpha, suggesting that targeted treatment using HIF-2 alpha and checkpoint inhibitors may be beneficial.

CANCERS (2023)

Article Medicine, General & Internal

Educational Scoring System in Laparoscopic Cholecystectomy: Is It the Right Time to Standardize?

Elisa Reitano, Simone Famularo, Bernard Dallemagne, Kohei Mishima, Silvana Perretta, Pietro Riva, Pietro Addeo, Horacio J. Asbun, Claudius Conrad, Nicolas Demartines, David Fuks, Mariano Gimenez, Melissa E. Hogg, Charles Chung-Wei Lin, Jacques Marescaux, John B. Martinie, Riccardo Memeo, Olivier Soubrane, Michel Vix, Xiaoying Wang, Didier Mutter

Summary: This study aims to create a scoring system to calculate the learning curve of laparoscopic cholecystectomy (LC) based on the opinions of hepatobiliopancreatic (HPB) experts. Variables were selected through a questionnaire and ranked by experts. The scoring system can be used to assess the efficacy of LC within educational programs and surgical courses.

MEDICINA-LITHUANIA (2023)

Review Medicine, General & Internal

Management of abdominal pseudotumours in haemophilia: a systematic review

Franz von Stauffenberg, Inga Hegemann, Rahel Schwotzer, Kuno Lehmann, Jeannette Widmer

Summary: This study evaluated therapy strategies for symptomatic abdominal haemophilic pseudotumours and found that primary surgical resection can be considered as the first-line treatment, with preoperative embolisation as a bridging therapy before surgery. Diagnostic biopsy and percutaneous drainage should be avoided to prevent complications.

SWISS MEDICAL WEEKLY (2023)

No Data Available